July 02, 2025 FDA Approves Ready-to-Infuse Vancomycin Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis. Conexiant
June 16, 2025 Combination of Weight Gain, Age at Pregnancy Could Increase Breast Cancer Risk The ASCO Post
June 30, 2025 FDA Approves Nivolumab With Ipilimumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer The ASCO Post
June 10, 2024 How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life The ASCO Post